Option Care Health Inc (OPCH)

Option Care Health's stock price has been significantly impacted by several events in the past six months. On April 30, 2026, the company's shares plunged after its Q1 2026 earnings report revealed a revenue miss and a sharp cut to its full-year 2026 revenue guidance. Following this news, multiple securities-fraud law firms launched investigations into Option Care Health, alleging potential securities law violations and misleading disclosures. Earlier in the six-month period, on January 12, 2026, Option Care Health announced preliminary unaudited financial results for Q4 and full-year 2025, and preliminary financial guidance for full-year 2026, which included net revenue projections of $5.8 billion to $6.0 billion.

While specific detailed information on the demand seasonality for Option Care Health's products and services is not explicitly provided, there is a mention of "seasonal expectations" in relation to operating cash flow. Management has indicated efforts to stabilize trends in the chronic inflammatory disease (CID) portfolio, which experienced a patient census reset. The increasing demand for home-based healthcare, particularly for chronic conditions, is a general driver for the home infusion market.

Option Care Health, Inc. is the largest independent provider of home and alternate site infusion services in the United States, operating within the healthcare sector. It specializes in administering injectable therapies and provides customized care plans and in-home nursing visits for patients managing complex or chronic conditions outside of a hospital setting. Its services include clinical management of infusion therapy, nursing support, and care coordination.

Option Care Health has a nationwide presence, licensed in all 50 states and serving patients across the United States and Puerto Rico. The company operates through a national network of infusion pharmacies and nursing professionals, with 157 ambulatory infusion suites and over 660 infusion seats. As of February 2024, it had 177 locations in 43 states.

Option Care Health's brand reputation has faced challenges in the past year. In December 2025, the company agreed to pay $719,265 for allegedly violating the Civil Monetary Penalties Law. More recently, in late April and early May 2026, the company's reputation was impacted by the announcement of securities fraud investigations by multiple law firms.

Institutional investors are the dominant shareholders of Option Care Health, holding a significant majority of the company's stock. As of July 2025, institutional investors held approximately 98.05% of Option Care Health's stock. Retail investors account for about 32.91% of ownership, while insiders hold a smaller percentage, around 1.27%.